1.Estimating the medical capacity required to administer mass prophylaxis: a hypothetical outbreak of smallpox virus infection in Korea
Sangwoo TAK ; Soomin LIM ; Heesu KIM
Epidemiology and Health 2019;41(1):2019044-
OBJECTIVES: The aim of this study was to estimate the medical surge capacity required for mass prophylaxis based on a hypothetical outbreak of smallpox.METHODS: We performed a simulation using the Bioterrorism and Epidemic Outbreak Response Model and varied some important parameters, such as the number of core medical personnel and the number of dispensing clinics.RESULTS: Gaps were identified in the medical surge capacity of the Korean government, especially in the number of medical personnel who could respond to the need for mass prophylaxis against smallpox.CONCLUSIONS: The Korean government will need to train 1,000 or more medical personnel for such an event, and will need to prepare many more dispensing centers than are currently available.
Bioterrorism
;
Korea
;
Smallpox
;
Surge Capacity
;
Vaccination
;
Variola virus
2.Production and Storage of Virus Simulants.
In Sun SHIN ; Doyeong KIM ; Sung Jun YANG ; Byoung Chul LIM ; Younggil CHA ; Seongjoo KIM ; Tae Ju CHO
Journal of Bacteriology and Virology 2018;48(2):37-48
We have examined isolation and identification protocols for three virus simulant candidates to biological warfare agents. MS2 phage, a simulant for yellow fever virus and Hantaan virus, was propagated using as a host an E. coli strain with F pilus. MS2 phage genome was examined by reverse transcription and polymerase chain reaction (RT-PCR). Coat protein of the phage preparation was examined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and mass spectrometric analysis. Cydia pomonella granulosis virus (CpGV) is a virus simulant candidate to smallpox virus. CpGV was isolated from a commercialized CpGV pellet. In this study, we developed new isolation and identification protocols for CpGV. One disadvantage of using CpGV is that it is not easy to determine viability of the virus. Here, we have included T4 phage as an alternative. We established a high titer production protocol and developed an easy genome identification protocol that does not require purified phage DNA. Stability of these virus preparations was also examined under various storage conditions. When the virus preparations were not subjected to freeze drying, MS2 phage was most stable when it was stored in liquid nitrogen but unstable at 4℃. In contrast, T4 phage was most stable when it was stored at 4℃. CpGV was stable at −20℃ but not at 4℃. Stability during or after freeze drying was also investigated. The result showed that 70~80% MS2 survived the freeze drying process. In contrast, only about 15% of T4 phage survived during the freeze drying. CpGV was found to be degraded during freeze drying.
Bacteriophage T4
;
Bacteriophages
;
Biological Warfare Agents
;
DNA
;
Electrophoresis
;
Freeze Drying
;
Genome
;
Granulovirus
;
Hantaan virus
;
Levivirus
;
Nitrogen
;
Polymerase Chain Reaction
;
Reverse Transcription
;
Variola virus
;
Yellow fever virus
3.Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.
Protein & Cell 2010;1(12):1084-1092
Vaccinia virus complement control protein (VCP) is one of the proteins encoded by vaccinia virus to modulate the host inflammatory response. VCP modulates the inflammatory response and protects viral habitat by inhibiting the classical and the alternative pathways of complement activation. The extended structure of VCP, mobility between its sequential domains, charge distribution and type of residues at the binding regions are factors that have been identified to influence its ability to bind to complement proteins. We report that a Lister strain of vaccinia virus encodes a VCP homolog (Lis VCP) that is functional, glycosylated, has two amino acids less than the well-characterized VCP from vaccinia virus WR strain (WR VCP), and the human smallpox inhibitor of complement enzymes (SPICE) from variola virus. The glycosylated VCP of Lister is immunogenic in contrast to the weak immunogenicity of the nonglycosylated VCP. Lis VCP is the only orthopoxviral VCP homolog found to be glycosylated, and we speculate that glycosylation influences its pattern of complement inhibition. We also correlate dimerization of VCP observed only in mammalian and baculovirus expression systems to higher levels of activity than monomers, observed in the yeast expression system.
Amino Acid Sequence
;
Animals
;
Cell Line
;
Cercopithecus aethiops
;
Complement Activation
;
drug effects
;
immunology
;
Complement System Proteins
;
metabolism
;
Dimerization
;
Gene Expression
;
Glycosylation
;
Humans
;
Molecular Sequence Data
;
Protein Binding
;
Protein Structure, Tertiary
;
Recombinant Proteins
;
genetics
;
metabolism
;
Smallpox
;
immunology
;
metabolism
;
Structure-Activity Relationship
;
Vaccinia virus
;
chemistry
;
immunology
;
metabolism
;
Variola virus
;
chemistry
;
immunology
;
metabolism
;
Viral Proteins
;
genetics
;
metabolism
;
pharmacology